Log in

LON:PXSProvexis Share Price, Forecast & News

GBX 0.85
+0.03 (+3.66 %)
(As of 05/29/2020 04:00 PM ET)
Today's Range
Now: GBX 0.85
50-Day Range
MA: GBX 0.59
52-Week Range
Now: GBX 0.85
Volume3.54 million shs
Average Volume688,515 shs
Market Capitalization£17.50 million
P/E RatioN/A
Dividend YieldN/A
Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Personal Products
SectorConsumer Goods



Sales & Book Value

Annual Sales£350,698.00



Outstanding Shares2,059,320,064
Market Cap£17.50 million
Next Earnings DateN/A
OptionableNot Optionable

Receive PXS News and Ratings via Email

Sign-up to receive the latest news and ratings for PXS and its competitors with MarketBeat's FREE daily newsletter.

Provexis (LON:PXS) Frequently Asked Questions

How has Provexis' stock been impacted by COVID-19 (Coronavirus)?

Provexis' stock was trading at GBX 0.52 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PXS shares have increased by 65.0% and is now trading at GBX 0.85. View which stocks have been most impacted by Coronavirus.

Has Provexis been receiving favorable news coverage?

Media stories about PXS stock have been trending very positive this week, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Provexis earned a daily sentiment score of 4.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View the latest news aboutProvexis.

Who are some of Provexis' key competitors?

What other stocks do shareholders of Provexis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Provexis investors own include Taylor Wimpey (TW), ValiRx (VAL), Sirius Minerals (SXX), Lloyds Banking Group (LLOY) and easyJet (EZJ).

Who are Provexis' key executives?

Provexis' management team includes the following people:
  • Mr. Ian Ford, CFO, COO, Company Sec. & Director (Age 53)
  • Dr. Niamh Ann O'Kennedy BSc, MSc, Ph.D., Chief Scientific Officer, Member of Scientific Advisory Board & Director (Age 45)
  • Prof. Asim K. Duttaroy BS MS Ph.D., DSc FICN, Consultant & Member of Scientific Advisory Board

What is Provexis' stock symbol?

Provexis trades on the London Stock Exchange (LON) under the ticker symbol "PXS."

How do I buy shares of Provexis?

Shares of PXS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Provexis' stock price today?

One share of PXS stock can currently be purchased for approximately GBX 0.85.

How big of a company is Provexis?

Provexis has a market capitalization of £17.50 million and generates £350,698.00 in revenue each year. Provexis employs 4 workers across the globe.

What is Provexis' official website?

The official website for Provexis is www.provexis.org.

How can I contact Provexis?

Provexis' mailing address is Prospect HSE, 58 Queens Road, READING, RG1 4RP, United Kingdom. The company can be reached via phone at +44-1753-861777.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.